Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylethyl Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105316250A reveals Empedobacter brevis strain for high-purity chiral alcohols. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.
Advanced asymmetric hydrogenation patent CN103232324B enables cost-effective production of chiral pharmaceutical intermediates with high conversion rates.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
Patent CN106957878B reveals a novel enzymatic route for 2-phenethyl alcohol using L-phenylalanine. Achieves high conversion without toxic byproducts, offering a reliable supply chain solution.